Padmanee Sharma

University of Texas at Houston - Department of Immunology

1515 Holocombe Blvd

Houston, TX 77030

United States

SCHOLARLY PAPERS

2

DOWNLOADS

75

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma (GBM) Patients

Number of pages: 99 Posted: 14 Oct 2018
University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, Baylor University, College of Medicine, Department of Neurology, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuropathology, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Radiology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology and University of Texas at Houston - Department of Neurosurgery
Downloads 39 (847,814)

Abstract:

Loading...

glioblastoma, immune checkpoint inhibitor, clinical trial, PD-1

2.

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma

Number of pages: 86 Posted: 19 Sep 2019
University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Strasbourg - Department of Hematology and Oncology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, Baylor University - Center for Precision Environmental Health, University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Texas at Houston - Department of Pathology, Baylor University - Department of Molecular and Cellular Biology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Genetics, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genitourinary Medical Oncology, University of Texas at Houston - Department of Genitourinary Medical Oncology, Baylor college of Medicine - Center for Precision Environmental Health, Baylor college of Medicine - Center for Precision Environmental Health, Baylor University - Department of Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Institute for Applied Cancer Science, University of Texas at Houston - Institute for Applied Cancer Science, University of Texas at Houston - Institute for Applied Cancer Science, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Urology, University of Texas at Houston - Department of Urology, Baylor college of Medicine - Center for Precision Environmental Health, University of Texas at Houston - Department of Genitourinary Medical Oncology and University of Texas at Houston - Department of Genitourinary Medical Oncology
Downloads 36 (872,199)

Abstract:

Loading...

Molecular profiling, renal medullary carcinoma, replication stress, SMARCB1, cGAS-STING pathway